Animal study · Supplements / medicine · 21 Oct 2026
Hot Topic | Three Years Later: Obesity Medications Have Changed – Has the Exercise Profession?
Source: ACSM
What the research found
The landscape of medications to treat obesity has rapidly changed since 2023 when we authored A Perspective on Anti-Obesity Medications. Semaglutide had captured public attention, tirzepatide was approaching approval for obesity, and dozens of new therapies were moving through development. The focus of our original perspective was: What does this mean for exercise professionals? Today, […] The post Hot Topic |
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34